Friedrichs, M. (2023). A web-based annotation tool for clinical trial failure reasons. GMS Medizinische Informatik, Biometrie Und Epidemiologie, 19, Doc02. doi: 10.3205/mibe000241

Filter:

Trial ID Phase Status Type
Results Reported Result Refs Exist Enrollment From To
Free Text
Annotations

7805 Trials matched filter criteria

Status:   Withdrawn   Suspended   Terminated
Trial Updated /
Type
Status Phase Were
Results
Reported
Reported
Actual
Enrollment
(MeSH) Terms Why Stopped
Limitations And Caveats
Annotator decisions
NCT00283049
Details
2011-01-13
Interventional
4390 
Insulin Insulin Glargin… Insulin glulisi… Insulin, Globin…
Diabetes Mellit… Diabetes Mellit…
Due to technical issues relating to the Electronic diary data.
The study was terminated prematurely due to technical issues with electronic diary data. Consequently, some of the initially planned efficacy analyses, based directly or indirectly on the e-diary data, were not performed.
NCT00790101
Details
2011-01-11
Interventional
46 
Raloxifene Hydr… Risedronic Acid
Osteoporosis Osteoporosis, P…
-
-
NCT00373789
Details
2011-01-11
Interventional
3
[1 Refs]
87 
Botulinum Toxin… Botulinum Toxin… abobotulinumtox…
Enuresis Urinary Inconti… Urinary Inconti… Detrusor Overac… Urge Urinary In… Urinary Urgency
higher than anticipated rate of increased post-void residual in subjects who received botulinum toxin A injection
-
NCT00237445
Details
2011-01-11
Interventional
4110 
Azithromycin Telithromycin
Pneumonia
-
-
NCT00651443
Details
2011-01-07
Interventional
1-
Galiximab
Lymphoma Lymphoma, Folli… Lymphoma, Non-H… Lymphoma, Non-H…
A company's strategic decision to focus on areas whereit believes it can be competitive and decided to exit Oncology
-
NCT00354562
2006-002838-38
Details
2011-01-07
Interventional
1/275 
Docetaxel
Carcinoma, Non-… Lung Neoplasms Lung Cancer Non-Small Cell …
-
-
NCT01271166
Details
2011-01-06
Interventional
110 
Bevacizumab Fluorouracil Imatinib Mesyla… Leucovorin Oxaliplatin
Colorectal Neop… Advanced Colore…
-
-
NCT00964665
2008-006933-29
Details
2011-01-06
Interventional
1/2141 
Interferon-alph… Peginterferon a…
Hepatitis Hepatitis A Hepatitis B Hepatitis B, Ch… Hepatitis, Chro… Chronic Hepatit…
-
-
NCT00286988
Details
2011-01-06
Interventional
4-
Topiramate
Vomiting
Insufficient potential subjects
-
NCT00242463
Details
2011-01-05
Interventional
2-
Anabolic Androg… Nandrolone Nandrolone Deca… Nandrolone phen…
Critical Illnes… Malnutrition
drug no longer available in canada
-
NCT00356200
Details
2010-12-22
Interventional
210 
Fluphenazine Fluphenazine de… Fluphenazine en…
Psoriasis
Enrollment criteria met
-
NCT00385593
2005-005974-64
Details
2010-12-16
Interventional
3654 
Budesonide Budesonide, For… Formoterol Fuma…
Asthma Asthma, Bronchi…
-
The study was prematurely stopped, because it was not possible to recruit the sample size required in the period of time established.
NCT01164540
Details
2010-12-10
Interventional
3-
Rosuvastatin Ca…
Embolism Pulmonary Embol… Thrombosis Venous Thrombos…
Due to discussion regarding the design of the study.
-
NCT00945178
2009-012114-43
Details
2010-12-10
Interventional
111 
Naproxen
Healthy Volunte…
The study was terminated due to results in another study (NCT00878501).
-
NCT00901290
Details
2010-12-10
Interventional
1-
Contraceptive A… Contraceptives,…
Pharmacokinetic…
suspended pending data analysis
-
NCT00888082
Details
2010-12-10
Interventional
3-
Goserelin
Breast Neoplasm… Breast Cancer Ovarian Functio…
-
-
NCT00733031
Details
2010-12-10
Interventional
1-
Gemcitabine Pemetrexed
Neoplasms Advanced Solid … Cancer, Solid Tumors
PK results demonstrate low and variable plasma concentrations so that achieving therapeutic concentrations is unlikely.
-
NCT00486798
2006-006426-26
Details
2010-12-10
Interventional
3-
Quetiapine Fuma…
Bipolar Disorde… Mental Disorder… Psychotic Disor… Schizophrenia
study was not ethically acceptable to continue and therefore it was finally stopped
-
NCT00458081
2006-002951-33
Details
2010-12-10
Interventional
3174 
Rimonabant
Diabetes Mellit… Diabetes Mellit… Dyslipidemias Obesity Dyslipidemia Microalbuminuri…
Company decision has been taken in light of recent demands by certain national health authorities
-
NCT00412698
2006-001715-30
Details
2010-12-10
Interventional
3645 
Rimonabant
Dyslipidemias Obesity
Company decision has been taken in light of recent demands by certain national health authorities
-